TY  - GEN
AU  - Voloshin,Tali
AU  - Kaynan,Noa
AU  - Davidi,Shiri
AU  - Porat,Yaara
AU  - Shteingauz,Anna
AU  - Schneiderman,Rosa S
AU  - Zeevi,Einav
AU  - Munster,Mijal
AU  - Blat,Roni
AU  - Tempel Brami,Catherine
AU  - Cahal,Shay
AU  - Itzhaki,Aviran
AU  - Giladi,Moshe
AU  - Kirson,Eilon D
AU  - Weinberg,Uri
AU  - Kinzel,Adrian
AU  - Palti,Yoram
TI  - Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
SN  - 1432-0851
PY  - 2020///0630
KW  - Animals
KW  - Antineoplastic Agents, Immunological
KW  - pharmacology
KW  - Apoptosis
KW  - Carcinoma, Hepatocellular
KW  - immunology
KW  - Carcinoma, Lewis Lung
KW  - Cell Proliferation
KW  - Combined Modality Therapy
KW  - Electric Stimulation Therapy
KW  - methods
KW  - Female
KW  - Humans
KW  - Immunogenic Cell Death
KW  - Liver Neoplasms
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Male
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Inbred C57BL
KW  - Programmed Cell Death 1 Receptor
KW  - antagonists & inhibitors
KW  - Tumor Cells, Cultured
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s00262-020-02534-7
ER  -